| SDs | Sleep disorders |
| MDD | Major depressive disorder |
| TCAs | Tricyclic drugs |
| 5-HT | Serotonin |
| SSRIs | Selective Serotonin Reuptake Inhibitor(s) |
| NE | Norepinephrine |
| SNRI | Serotonin–norepinephrine reuptake inhibitors |
| DXT | Duloxetine |
| DVS | Desvenlafaxine succinate |
| GAD | Generalized Anxiety Disorder |
| SAD | Social Anxiety Disorder |
| PTSD | Post-traumatic stress disorder |
| OCD | Obsessive–compulsive disorder |
| PSD | Post-stroke depression |
| CGA | Chlorogenic acid |
| FA | Ferulic acid |
| CA | Caffeic acid |
| DA | Dopamine |
| PFC | Prefrontal Cortex |
| A1R | A1 receptors |
| A2AR | A2A receptors |
| ACTH | adrenocorticotropic hormone |
| DMN | Default mode network |
| MAO-A | Monoamine oxidase-A |
| DSM-IV | Diagnostic and Statistical Manual of Mental Disorders-IV |
| SPT | Sugar preference test |
| FST | Forced swim test |
| TST | Tail suspension test |
| OFT | Open field test |
| IL-6 | Interleukin-6 |
| TNF-α | Tumor necrosis factor-α |
| SOD | Superoxide dismutase |
| GPx | Glutathione peroxidase |
| PDD | Postpartum Depression |
| IDO | Indoleamine 2, 3-dioxygenase |
| LPS | Lipopolysaccharide |
| UA | Uric acid |
| 3-HK | 3-Hydroxykynurenine |
| KYN | Kynurenine |
| KP | Kynurenine pathway |
| CNS | Central Nervous System |
| CUS | Chronic unpredictable stress |
| LTP | Long-term potentiation |
| CORT | Corticosterone |
| MAPK | Mitogen-activated protein kinase |
| ERK | Extracellular regulated protein kinases |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| CWIRS | Chronic water immersion restraint stress |
| CMS | Chronic Mild Stress |
| PGC-1α | Peroxisome proliferators-activated receptor γ coactivator lα |
| KAT | Kynurenine aminotransferase |
| KYNA | Kynurenic acid |
| SRS | Stress-induced stress |
| PGE2 | Prostaglandin E2 |
| BrdU | Bromodeoxyuridine |
| DCX | Doublecortin |
| IL-1β | Interleukin-1β |
| SNAP-25 | Synaptosomal-Associated Protein 25 |
| IFN-γ | Interferon-gamma |
| MDA | Malondialdehyde |
| BDNF | Brain-derived neurotrophic factor |
| GSH | Glutathione |
| GR | Glucocorticoid receptor |
| ADRA1A | α1Aadrenoreceptor |
| TBARS | Thiobarbituric acid reactive substances |
| AChE | Acetylcholinesterase |
| OS | Oxidative stress |
| Nrf2 | Nuclear factor-erythroid 2 related factor 2 |
| EPM | Elevated plus maze test |
| LDB | Light/dark box test |
| IAT | Inhibitory avoidance test |
| FET | Free exploration test |
| PNS | Peripheral nervous system |
| MWM | Morris water maze |
| MBT | Marble burying test |
| 5-HTP | 5-Hydroxytryptophan |
| REM | Rapid eye movement sleep |
| NREM | Non-rapid eye movement sleep |
| Per1/Per2 | Period Circadian Regulator 1/2 |
| α1-AR | α1-adrenergic receptor |
| iTBS | Intermittent burst theta stimulation |
| dmPFC | Dorsomedial prefrontal cortex |
| SBP | Systolic Blood Pressure |
| DBP | Diastolic Blood Pressure |
| CR | Circadian Rhythm |
| EEG | Electroencephalogram |
| ICCA | Isochlorogenic acid |
| SYG | Syringaresinol-di-O-glucoside |
| GSK-3β | Glycogen synthase kinase-3β |
| OAB | Overactive bladder |
| CSF | Cerebrospinal fluid |
| SCN | Suprachiasmatic nucleus |
| CREB | Cyclic-AMP response binding protein |
| OXRs | Orexin receptor antagonists |
| NMDA | N-methyl-d-aspartate |
| PKC | Protein kinase C |
| cAMP | Cyclic adenosine monophosphate |
| LS | Lateral septal |
| SNP | Single nucleotide polymorphism |
| PAG | Periaqueductal gray |
| mPFC | Medial prefrontal cortex |
| AANAT | Aryl alkylamine N-acetyltransferase |
| CRTC1 | CREB-regulated transcription coactivator 1 |
| CRE | cAMP response element |
| PI3K | Phosphatidylinositol 3-kinase |
| mTOR | Mechanistic target of rapamycin |
| TrkB | Tropomyosin-related kinase B |
| PLC-γ | Phospholipase C-γ |
| AMPAR | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor |
| NAc | Nucleus accumbens |
| IRS2 | Insulin receptor substrate 2 |
| CAFLTP | Caffeine-induced LTP |
| P-CaMKII | Phosphorylated calcium calmodulin kinase I |
| GABA | Gamma-aminobutyric acid |
| CCK | Cholecystokinin |
| AvBNST | Anteroventral nucleus of the bed nucleus of the stria terminalis |
| VTA | Ventral tegmental area |
| DRN | Dorsal raphe nucleus |
| BLA | Basal lateral amygdala |
| ROS | Reactive oxygen species |
| HPA axis | hypothalamic–pituitary–adrenal axis |
| GCs | Glucocorticoids |
| H2O2 | Hydrogen peroxide |
| ·OH | Hydroxyl radicals |
| ROO· | Peroxyl radicals |
| 1O2 | Singlet oxygen |
| JNK1/2 | c-Jun N-terminal kinase 1/2 |
| CCL2 | C-C motif chemokine ligand-2 |
| CRP | C-reactive protein |
| TDO | Tryptophan 2,3-dioxygenase |
| NKA | Na+/K+-ATPase |
| IκBα | Inhibitor of nuclear factor kappa-Bα |
| CRH | Corticotropin releasing hormone |
| CAR | Cortisol awakening response |
| CRF | Corticotrophin releasing factor |
| MRs | Mineralocorticoid receptors |
| MGB axis | Microbiota-Gut–Brain axis |
| SCFAs | Short-chain fatty acids |
| HIF-1 | Hypoxia-inducible factor-1 |
| CUMS | Chronic unpredictable mild stress |
| FMT | Fecal microbiota transplantation |
| 4EPS | 4-Ethylphenyl sulfate |
| MP | Muramyl peptides |
| EC | Enterochromaffin cells |